Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

NCT00415805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Steno-occlusive Disease

Interventions

DRUG: Multihance
DRUG: vasovist

Sponsor

Bracco Diagnostics, Inc